TCL Archive Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate February 14, 2014
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan. March 12, 2004
TCL Archive BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions July 4, 2014
